1Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials[J].Lancet 2003; 361(9351):13-20. 被引量：1
2Antman EM,Hand M,Armstrong PW,et al.2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines:developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians:2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction,Writing on Behalf of the 2004 Writing Committee[J].Circulation,2008,117(2):296-329. 被引量：1
3van't Hof AW,Liem A,Suryapranata H,et al.Angio-graphic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction:myocardial blush grade Zwolle Myocardial Infarction Study Group[J].Circulation,1998,97(23):2302-2306. 被引量：1
4De Luca G,van't Hof AW,Ottervanger JP,et al.Unsuccessful reperfusion in patients with ST-segmentelevation myocardial infarction treated by primary angioplasty[J].Am Heart J,2005,150(3):557-562. 被引量：1
6White H,Hirulog and Early Reperfusion or Occlusion(HERO)-2 Trial Investigators.Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction:the HERO-2 randomised trial.Hirulog and Early Reperfusion or Occlusion(HERO)Study Group[J].Lancet,2001,358(9296):1855-1863. 被引量：1
7Mehran R,Lansky AJ,Witzenbichler B,et al.Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction(HORIZONS-AMI):1-year results of a randomised controlled trial[J].Lancet,2009,374(9696):1149-1159. 被引量：1
8De Luca G,Marino P.Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis.A meta-analysis of the randomized trials[J].Am Heart J,2007,154(6):1085.el-e6. 被引量：1
9Sinnaeve PR.Huang Y,Bogaerts K.et al.Age,outcomes,and treatment effects of fibrinolytic and antithrombotic combinations:findings from Assessment of the Safety and Efficacy of a New Thrombolytic(ASSENT)-3 and ASSENT-3 PLUS[J].Am Heart J,2006,152:684.e1-e9. 被引量：1
10White HD.Braunwald E,Murphy SA,et al.Enoxaparin vs.unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients:results from ExTRACT-TIMI 25[J].Eur Heart J,2007,28(9):1066-1071. 被引量：1
6Abdul-Rahman S, Nammas W, Gamal A, et al. Routine invasive versus isehemia-guided strategy in patients with a- cute inferior ST-elevation myocardial infarction who re- ceived fibrinolytic therapy., a prospective randomized con- trolled pilot trial[J]. J Invasive Cardiol, 2011,23 (8) : 316- 321. 被引量：1
7Williams B, Lacy PS, Thorn SM et al. Differential impact of blood pressure-lowering drugs on central aortic pres- sure and clinical outcomes., principal results of the Conduit Artery Function Evaluation (CAFE) study [J ]. Circula- tion,2006,113(9) :1213 1225. 被引量：1
8Fagard RH, Thijs L, Staessen JA, et al. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension[J]. J Hum Hypertens, 2009,23 (10) : 645-653. 被引量：1
9Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the ohasama study[J]. Hy pertension, 2005,45 (2) : 240-245. 被引量：1
10Metoki H, Ohkubo T, Kikuya M, et al. Prognostic signifi cance for stroke of a morning pressor surge and a noctur nal blood pressure decline:the ohasama study[J]. Hyper tension,2006,47(2) : 149-154. 被引量：1
